Delivery Order SPE2DB22D3501-SPE2DB24FTU65
Award Date 12/8/23
Potential Completion Date 12/11/23
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ciprofloxacin-Dexamethasone otic suspension (7.5 mL) for a ceiling value of $1,165.68. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential total value of $999,999,999.00 and a performance period through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,588.37 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ciproflox-Dexameth Otic Suspension 7.5ML. This is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ciproflox-Dexameth Otic Suspension. The contract has a ceiling value of $1,107.53 and a period of performance through March 29, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product. The award, valued at $3,197.15, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a potential ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ciproflox-Dexameth Otic Suspension 7.5 ML to support military treatment programs and facilities. The contract has a ceiling value of $1,604.16 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciproflox-Dexameth Otic Suspension, a specialty pharmaceutical product. The contract has a ceiling value of $1,257.27 and a completion date of May 10, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ciproflox-Dexameth Otic Suspension 7.5ML. The contract, valued at $6,092.84, is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen. The IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has a ceiling value of $1,493.78 and is a delivery order contract for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, with a ceiling value of $7,892.63 and an ultimate completion date of February 6, 2024. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor with no major subcontractors listed. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,827.00 delivery order is for the pharmaceutical product Ciproflox-Dexameth Otic Suspension, a medication used to treat ear infections. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTU65Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ciproflox-Dexameth Otic Suspension 7.5 mL. The contract has a ceiling value of $1,567.17 and an ultimate completion date of December 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 5/12/25, 9:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/8/23 |